Soy peptide-induced stem cell proliferation: Involvement of ERK and TGF-β1

Journal of Nutritional Biochemistry

Volumn 23, Issue 10, 2012, Pages 1341-1351

  Lee, Jienny ^a   Roh, Kyung Baeg ^a   Kim, Sang Cheol ^a   Lee, Jongsung ^a   Park, Deokhoon ^a  

^a Biospectrum Life Science Institute   (South Korea)

Author keywords

Adult stem cells; ERK; Growth factor; MTOR pathway; Soy peptide; TGF 1

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CYTOKINE; INITIATION FACTOR 4E; INTERLEUKIN 6; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN SOY; RIBOSOME PROTEIN; S6 KINASE; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; VASCULOTROPIN; VEGETABLE PROTEIN;

ADIPOSE TISSUE; ADULT STEM CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; SERUM; SOYBEAN; STEM CELL;

CELL LINE; CELL PROLIFERATION; DEOXYURIDINE; EUKARYOTIC INITIATION FACTOR-4E; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-6; MAP KINASE SIGNALING SYSTEM; MESENCHYMAL STROMAL CELLS; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHORYLATION; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; SIGNAL TRANSDUCTION; SOYBEAN PROTEINS; TETRAZOLIUM SALTS; THIAZOLES; TOR SERINE-THREONINE KINASES; TRANSFORMING GROWTH FACTOR BETA1; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EUKARYOTA; MAMMALIA;

EID: 84866328682     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2011.08.003     Document Type: Article

References (47)

1. Banfi A., Muraglia A., Dozin B., Mastrogiacomo M., Cancedda R., Quarto R. Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: implications for their use in cell therapy. Exp Hematol 2000, 28:707-715.
2. Wagner W., Horn P., Castoldi M., Diehlmann A., Bork S., Saffrich R., et al. Replicative senescence of mesenchymal stem cells: a continuous and organized process. PLoS One 2008, 21:e2213.
3. Bork S., Pfister S., Witt H., Horn P., Korn B., Ho A.D., et al. DNA methylation pattern changes upon long-term culture and aging of human mesenchymal stromal cells. Aging Cell 2010, 9:54-63.
4. Loewith R., Hall M.N. TOR signaling in yeast: temporal and spatial control of cell growth. Cell growth: control of cell size 2004, 139. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York. M.N. Hall, M. Raff, G. Thomas (Eds.).
5. Pullen N., Thomas G. The modular phosphorylation and activation of p70S6K. FEBS Lett 1997, 410:78-82.
6. Dufner A., Thomas G. Ribosomal S6 kinase signaling and the control of translation. Exp Cell Res 1999, 253:100-109.
7. Istfan N., Murray E., Janghorbani M., Evans W.J., Young V.R. The nutritional value of a soy protein concentrate (STAPRO-3200) for long-term protein nutritional maintenance in young men. J Nutr 1983, 113:2524-2534.
8. Tham D.M., Gardner C.D., Haskell W.L. Potential health benefits of dietary phytoestrogens: a review of the clinical, epidemiological, and mechanistic evidence. J Clin Endocrinol Metab 1998, 83:2223-2235.
9. Yamasaki M., Fujita S., Ishiyama E., Mukai A., Madhyastha H., Sakakibara Y., et al. Soy-derived isoflavones inhibit the growth of adult T-cell leukemia cells in vitro and in vivo. Cancer Sci 2007, 98:1740-1746.
10. Sakai K., Matsunaga T., Hayashi C., Yamaji H., Fukuda H. Effects of phosphatidic acid on recombinant protein production by Chinese hamster ovary cells in serum-free culture. Biochem Eng J 2002, 10:85-92.
11. Jan D.C.-H., Jones S.J., Emery A.N., al-Rubeai M. Peptone, a low-cost growth-promoting nutrient for intensive animal cell culture. Cytotechnology 1994, 16:17-26.
12. Schlaeger E.J. The protein hydrolysate, Primatone RL, is a cost-effective multiple growth promoter of mammalian cell culture in serum-containing and serum-free media and displays anti-apoptosis properties. J Immunol Methods 1996, 194:191-199.
13. Shacter E. Serum-free medium for growth factor-dependent and -independent plasmacytomas and hybridomas. J Immunol Methods 1987, 99:259-270.
14. Jager V., Lehmann J., Friedle P. Serum-free growth medium for the cultivation of a wide spectrum of mammalian cells in stirred bioreactors. Cytotechnology 1988, 1:319-329.
15. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
16. Asnaghi L., Bruno P., Priulla M., Nicolin A. mTOR: a protein kinase switching between life and death. Pharmacol Res 2004, 50:545-549.
17. Beugnet A., Wang X., Proud C.G. Target of rapamycin (TOR)-signaling and RAIP motifs play distinct roles in the mammalian TOR-dependent phosphorylation of initiation factor 4E-binding protein 1. J Biol Chem 2003, 278:40717-40722.
18. Nojima H., Tokunaga C., Eguchi S., Oshiro N., Hidayat S., Yoshino K., et al. The mammalian target of rapamycin (mTOR) partner, raptor, binds the mTOR substrates p70 S6 kinase and 4E-BP1 through their TOR signaling (TOS) motif. J Biol Chem 2003, 278:15461-15464.
19. Hay N., Sonenberg N. Upstream and downstream of mTOR. Genes Dev 2004, 18:1926-1945.
20. Wagner W., Wein F., Seckinger A., Frankhauser M., Wirkner U., Krause U., et al. Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp Hematol 2005, 33:1402-1416.
21. Caplan A.I. Mesenchymal stem cells and gene therapy. Clin Orthop Relat Res 2000, 379:67-70.
22. Tsang C.K., Qi H., Liu L.F., Zheng X.F. Targeting mammalian target of rapamycin (mTOR) for health and diseases. Drug Discov Today 2007, 12:112-124.
23. Hara K., Maruki Y., Long X., Yoshino K., Oshiro N., Hidayat S., et al. Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell 2002, 110:177-189.
24. Kim D.H., Sarbassov D.D., Ali S.M., King J.E., Latek R.R., Erdjument-Bromage H., et al. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 2002, 110:163-175.
25. Gingras A.C., Raught B., Sonenberg N. eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. Annu Rev Biochem 1999, 68:913-963.
26. Waskiewicz A.J., Johnson J.C., Penn B., Mahalingam M., Kimball S.R., Cooper J.A. Phosphorylation of the cap-binding protein eukaryotic translation initiation factor 4E by protein kinase Mnk1 in vivo. Mol Cell Biol 1999, 19:1871-1880.
27. Strawn L.M., McMahon G., App H., Schreck R., Kuchler W.R., Longhi M.P., et al. Flk-1 as a target for tumor growth inhibition. Cancer Res 1996, 56:3540-3545.
28. Ferrara N. Molecular and biological properties of vascular endothelial growth factor. J Mol Med 1999, 77:527-543.
29. Fong T.A., Shawver L.K., Sun L., Tang C., App H., Powell T.J., et al. SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types. Cancer Res 1999, 59:99-106.
30. Geng L., Donnelly E., McMahon G., Lin P.C., Sierra-Rivera E., Oshinka H., et al. Inhibition of vascular endothelial growth factor receptor signaling leads to reversal of tumor resistance to radiotherapy. Cancer Res 2001, 61:2413-2419.
31. Carmeliet P. Angiogenesis in health and disease. Nat Med 2003, 9:653-660.
32. Kimura T., Boehmler A.M., Seitz G., Kuçi S., Wiesner T., Brinkmann V., et al. The sphingosine 1-phosphate receptor agonist FTY720 supports CXCR4-dependent migration and bone marrow homing of human CD34+ progenitor cells. Blood 2004, 103:4478-4486.
33. Eichmann A., Yuan L., Moyon D., Lenoble F., Pardanaud L., Breant C. Vascular development: from precursor cells to branched arterial and venous networks. Int J Dev Biol 2005, 49:259-267.
34. Wang S., Li X., Parra M., Verdin E., Bassel-Duby R., Olson E.N. Control of endothelial cell proliferation and migration by VEGF signaling to histone deacetylase 7. Proc Natl Acad Sci USA 2008, 105:7738-7743.
35. Gerber H.P., Malik A.K., Solar G.P., Sherman D., Liang X.H., Meng G., et al. VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism. Nature 2002, 417:954-958.
36. Nakagami H., Maeda K., Morishita R., Iguchi S., Nishikawa T., Takami Y., et al. Novel autologous cell therapy in ischemic limb disease through growth factor secretion by cultured adipose tissue-derived stromal cells. Arterioscler Thromb Vasc Biol 2005, 25:2542-2547.
37. Heinrich P.C., Behrmann I., Müller-Newen G., Schaper F., Graeve L. Interleukin-6-type cytokine signaling through the gp130/Jak/STAT pathway. Biochem J 1998, 334:297-314.
38. Ihle J.N. The Stat family in cytokine signaling. Curr Opin Cell Biol 2001, 13:211-217.
39. Kamimura D., Ishihara K., Hirano T. IL-6 signal transduction and its physiological roles: the signal orchestration model. Rev Physiol Biochem Pharmacol 2003, 149:1-38.
40. Pepper M.S. Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity. Cytokine Growth Factor Rev 1997, 8:21-43.
41. Jeon S.H., Chae B.C., Kim H.A., Seo G.Y., Seo D.W., Chun G.T., et al. Mechanisms underlying TGF-β1-induced expression of VEGF and Flk-1 in mouse macrophages and their implications for angiogenesis. J Leukoc Biol 2007, 81:557-566.
42. Saadeh P.B., Mehrara B.J., Steinbrech D.S., Dudziak M.E., Greenwald J.A., Luchs J.S., et al. Transforming growth factor-beta1 modulates the expression of vascular endothelial growth factor by osteoblasts. Am J Physiol 1999, 277:628-637.
43. Renner U., Lohrer P., Schaaf L., Feirer M., Schmitt K., Onofri C., et al. Transforming growth factor-beta stimulates vascular endothelial growth factor production by folliculostellate pituitary cells. Endocrinology 2002, 143:3759-3765.
44. Koochekpour S., Merzak A., Pilkington G.J. Vascular endothelial growth factor production is stimulated by gangliosides and TGF-β isoforms in human glioma cells in vitro. Cancer Lett 1996, 102:209-215.
45. Pertovaara L., Kaipainen A., Mustonen T., Orpana A., Ferrara N., Saksela O., et al. Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells. J Biol Chem 1994, 4:6271-6274.
46. Kitamura S., Maeshima Y., Sugaya T., Sugiyama H., Yamasaki Y., Makino H. Transforming growth factor-β1 induces vascular endothelial growth factor expression in murine proximal tubular epithelial cells. Nephron Exp Nephrol 2003, 95:79-86.
47. Pelaia G., Gallelli L., D'Agostino B., Vatrella A., Cuda G., Fratto D., et al. Effects of TGF-beta and glucocorticoids on map kinase phosphorylation, IL-6/IL-11 secretion and cell proliferation in primary cultures of human lung fibroblasts. J Cell Physiol 2007, 210:489-497.